|
⚲
|
| Oraya Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001395387 |
| Sale | 2009-07-17 ($20.9 M Offered, $20.9 M Sold) |
| Fund | |
| Phone | 5104563702 |
| Address | 8000 Jarvis Avenue Newark, 94560 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Brian Halak | |
| Reza Zadno | |
| Michael Gertner | |
| John Onopchenko | |
| Guido Neels | |
| Mark Brooks | |
| Peter Cohn |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Blacklist Equity Fund II, LLC
✚
|
0.0 | |
|
Black Philip Douglas
✚
|
0.0 | |
|
Black Randall E
✚
|
0.0 | |
|
Black Richard B
✚
|
0.0 | |
|
BlackRock Debt Strategies Fund Inc
✚
|
0.0 | |
|
BlackRock Diversified Private Opportunities Fund II, L.P.
✚
|
0.0 | |
|
BlackRock Floating Rate Income Trust
✚
|
0.0 | |
|
BlackRock Global Market Strategies Fund Ltd.
✚
|
0.0 | |
|
BlackRock Gold Corp
✚
|
0.0 | |
|
Blackley Ian T
✚
|
0.0 |